Anaphylaxis
exp date isn't null, but text field is
Anaphylaxis is a severe, life-threatening, generalised or systemic hypersensitivity reaction characterised by rapidly developing life-threatening airway (pharyngeal or laryngeal edema) and/or breathing (bronchospasm and tachypnea) and/or circulation (hypotension and tachycardia) problems usually associated with skin and mucosal changes.
Clinical presentation
- Hives
- Angioedema
- Wheezes
- Difficult breathing
- Diarrhoea
- Hypotension
Anaphylaxis is a clinical diagnosis and should be suspected when:
- Acute onset involving skin, mucosal tissue with either respiratory compromization or blood pressure reduction (or syncope)
- Hypotension after exposure to a known allergy for the patient (SBP <90mmHg or >30% from baseline)
- Respiratory compromise (i.e dyspnoea, stridor, wheeze, hypoxemia)
- Exposure to a likely allergen causing involvement of the skin, mucosal, respiratory compromization or blood pressure reduction
Investigations
Blood gases, Serum Electrolytes, POC ECG, Troponin, CXR and/or POC USS
Non pharmacological management
- Perform both primary and secondary assessment. If patient has signs of severe respiratory distress perform early intubation/surgical airway
- Give oxygen if hypoxic (spO2 below 95%) or severe respiratory distress
- Insert TWO large bore IV cannulas or obtain intraoseous access
Pharmacological Management
A: adrenaline (IM): Adult 0.3-0.5mg (maximum 0.5mg) every 5-15min as soon as possible. If inadequate response, start adrenaline (IV) 2-10mcg/min in 0.9% sodium chloride (IV) OR Ringer lactate (IV) 1-2 litres. If hypotensive. Repeat IV fluids as needed; Paediatric 0.01mg/kg, every 5-15min as soon as possible. If inadequate response, start adrenaline (IV) 0.05- 1mcg/kg/min in 0.9% sodium chloride (IV)ORcompound sodium lactate (IV) 20mls/kg if hypotensive. Repeat IV fluids as needed
OR
A: hydrocortisone (IV)200mg stat
OR
B: salbutamol (nebulisation) 10mg and equal volume of water for injection (This is useful to
patients with refractory bronchospasm).
OR
D: methylprednisolone (IV) 1-2mg/kg/day
Disposition
All patient with severe and moderate symptoms which required repeated doses of adrenaline or didn’t respond to treatment must be admitted or referred to higher health facility. Those with mild response which responded to IM adrenaline may be discharged after 4 hours’ observation at the health facility.